Menu
Close
.svg)
“Do you mind if I record our visit?”
You’re siting on the exam table about to start your annual physical. The physician sets her phone down between you, screen dark, microphone on. “It helps me write my note so I can focus on you.”
You give your consent. What follows feels different. She isn’t half-turned toward a keyboard. There’s no rhythmic typing, no apologetic glances resulting from divided attention. There is conversation -- some of it clinical, some of it not.
This moment -- simple, almost mundane -- signals a deeper shift underway in medicine. Ambient scribes that use genAI are quietly moving from experimental technology to infrastructure.
And their implications could extend well beyond documentation.
Fundamentally, an ambient scribe “listens” to the HCP–patient encounter, converts speech to text, structures it into a clinical note, and presents it for physician review and signature. Increasingly these systems are gaining in functionality and sophistication, e.g., suggesting billing codes, identifying documentation gaps, and integrating clinical references; and a growing number of vendors are now active in this space.
Notable examples include Abridge, which has been widely deployed in large health systems; DeepScribe, known for specialty-focused ambient AI; Ambience Healthcare, whose platform combines ambient documentation with coding and workflow support; and Microsoft’s Nuance Dragon Ambient eXperience (DAX), embedded into broader clinical documentation suites. Other players include Suki AI, Heidi Health, Twofold Health, and Nabla, each offering variations on ambient listening, summarization, and EHR integration tailored to HCPs’ workflows. These tools illustrate how ambient AI is maturing from basic transcription to a multifunctional clinical assistant embedded in the exam room.
The early promise was HCP relief: less typing, fewer after-hours notes... ideally leading to less burnout. Health systems moved quickly. NHS pilots report improved productivity and more time spent in direct patient care. U.S. deployments now span hundreds of hospital systems. But documentation is just the foothold. Once an AI system sits inside the clinical workflow, aware of context, diagnosis, treatments and/or medications, and conversational nuance, it becomes capable of much more than transcription.
It has the potential to become a coordinating layer across the encounter.
Before we get to the strategic implications, it’s worth pausing to consider something more human.
A retired physician recently wrote about his annual primary care visit: an exam, labs, and 10–12 minutes of small talk about family and politics. When his physician’s practice adopted an ambient scribe, his immediate question wasn’t about productivity metrics. It was about whether the small talk would end up immortalized in the medical record.
Short answer: it doesn’t.
Modern systems are increasingly precise in parsing medically relevant content from the natural cadence of conversation. Anecdotes about a resilient garden or a busy soccer schedule are recognized for what they are -- relational context, not clinical information -- and excluded from the documentation.
That distinction matters.
Small talk is not trivial. It is how rapport is built. It is how patients become people rather than clinical subjects. Over the years, documentation burdens and templated EHR workflows squeezed out those moments. Ambient AI tools, when implemented thoughtfully, appear to be giving some of that space back.
The technology works best when it recedes.
For those of us who spend our days learning about patient journeys, running campaign tests, and measuring share shifts down to the decimal point, this isn’t soft or sentimental. It’s practical.
Trust shows up in the data. It shows up in whether a prescription is filled, whether a patient comes back for follow-up visit, whether she or he sticks with treatment long enough to see it work. We model adherence curves and switching behavior, but underneath those charts are human interactions.
If ambient tools give HCPs even a few more minutes of undistracted attention -- if they make it easier to look a patient in the eye instead of at a screen -- that changes the culture of the encounter. And that affects decisions. Decisions affect behavior. Behavior affects outcomes.
Presence in the exam room is not a nice-to-have. It has measurable consequences.
The more consequential development is how ambient platforms are expanding beyond note generation. Leading vendors are layering in:
Rather than forcing HCPs to toggle among separate vendors -- dictation, coding, literature search, prior auth portals -- the ambition is to unify these functions into one continuous workflow.
This reduces friction. It also centralizes influence.
If a system can recognize, during the visit, that a prescribed therapy will require prior authorization and can draft the documentation accordingly, the gap between clinical intent and payer approval narrows. If relevant literature can be surfaced contextually without copy-paste into a chatbot, evidence becomes part of the live conversation.
The exam room becomes digitally assisted, but not digitally dominated.
Adoption of the ambient scribe has not been without controversy. A recent lawsuit in California alleges that patients were recorded without adequate consent. The claim is less about AI itself and more about process: disclosure, documentation of consent, data retention practices.
This is instructive.
Ambient AI alters the sensory landscape of the visit. Audio is captured. Cloud processing is involved. Even when compliant with HIPAA and other privacy frameworks, the optics matter.
Here are some of the best practices that are emerging:
Health systems that treat consent as boilerplate risk eroding trust. Vendors that minimize governance in pursuit of scale will face friction.
For industry stakeholders observing from the sidelines, it is worth noting that ambient AI is not purely a technology story. It is a trust architecture story.
For commercial, insights, and analytics professionals, the more pressing question is how this reshapes the informational and behavioral environment in which therapies are selected for the patient.
AI-generated notes tend to be more complete and consistently structured. Fewer abbreviations. Fewer omissions. Standardized formatting.
Over time, this will improve the fidelity of structured EHR data and secondary data extracts. Real-world evidence programs may benefit from more consistent capture of symptom descriptions, AEs, and treatment rationales.
Forecasting models built on noisy, error-prone documentation may need recalibration.
If prior authorization prompts occur in real time, and draft submissions are generated before the patient leaves, treatment initiation timelines may compress.
For high-cost or specialty products, this changes the access equation. Payer requirements become visible earlier. Documentation quality improves. The role of hub services may evolve.
Manufacturers should anticipate a shift from reactive reimbursement support to anticipatory access design.
When clinical decision support (CDS) tools draw on integrated literature sources, the representation of data within those systems becomes strategically relevant.
Medical affairs teams will need to think carefully about how their published data are indexed, summarized, and presented within AI-assisted clinical workflows and CDS modules. Traditional detailing and peer-to-peer engagement remain essential. But when evidence is surfaced directly inside the exam room, i.e., embedded in documentation or CDS, it becomes part of the physician’s real-time thought process.
That kind of integration won’t necessarily overturn established prescribing habits overnight. What it can do is shape close calls: which therapy is selected first, which alternative is considered, how risk–benefit tradeoffs are framed in conversation with the patient. When evidence is woven into the workflow rather than delivered separately, it has a different kind of influence: quieter, but potentially powerful.
This is not about manipulating algorithms. It is about ensuring high-quality, peer-reviewed data are accessible and accurately represented within the knowledge infrastructure clinicians rely upon.
If ambient tools genuinely reduce administrative burden, HCPs may reallocate time and attention. Some of that may go back to small talk. Some may go toward more nuanced therapeutic discussions.
Either way, the tempo of the encounter could change.
Engagement strategies that assume harried, distracted physicians may need revision. Conversations about comparative data, value propositions, and patient support could become more substantive.
It is tempting to view ambient scribes as another digital upgrade, akin to e-prescribing or patient portals. That would underestimate what's happening.
This isn’t just a documentation tool. It touches the note, the billing process, the clinical thinking behind a decision, and the way the visit feels to the patient. It "listens" to the conversation, actually "hears" it more thoroughly than a human, transforms it into something structured, and increasingly, offers suggestions along the way.
And yet, its success depends on its ability to disappear: to allow the physician to ask about youth hockey or a struggling garden without turning the encounter into a transcript of trivialities.
The exam room has always been a place of stories. Ambient AI does not eliminate them. It filters, organizes, and occasionally augments them.
For those of us in pharma and biotech, the task is not to react to headlines about AI scribes. It is to understand how a more structured, context-aware, and friction-reduced clinical workflow alters data generation, access pathways, and evidence influence.
The physician sets down her phone. The patient nods. The conversation unfolds: clinical facts woven with fragments of life.
The system listens quietly in the background.
Strategy, as always, begins with understanding what has changed in the room.
